Daiichi Sankyo begins phase I study in Japan with DS-2741a for atopic dermatitis Jan. 27, 2020 No Comments
Phase III BREEZE-AD4 trial of baricitinib in atopic dermatitis meets primary endpoint Jan. 27, 2020 No Comments
Phase III study of AKP-01 spray in mild to moderate plaque psoriasis meets primary endpoint Jan. 27, 2020 No Comments
Abeona initiates phase III study of EB-101 in recessive dystrophic epidermolysis bullosa Jan. 14, 2020 No Comments
Positive topline data from phase Ib study of CBP-201 in moderate to severe atopic dermatitis Jan. 9, 2020 No Comments
Sol-Gel initiates phase I study of SGT-210 in punctate palmoplantar keratoderma Jan. 3, 2020 No Comments
Novan reports topline efficacy data from phase III B-SIMPLE program of SB-206 for molluscum Jan. 3, 2020 No Comments
RSS